2020
DOI: 10.1530/ec-20-0225
|View full text |Cite
|
Sign up to set email alerts
|

The functional duality of SGK1 in the regulation of hyperglycemia

Abstract: Hyperglycemia is the consequence of blood glucose dysregulation and a driving force of diabetic complications including retinopathy, nephropathy and cardiovascular diseases. The serum and glucocorticoid inducible kinase-1 (SGK1) has been suggested in the modulation of various pathophysiological activities. However, the role of SGK1 in blood glucose homeostasis remains less appreciated. In this review, we intend to summarize the function of SGK1 in glucose level regulation and to examine the evidence su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 70 publications
0
7
0
Order By: Relevance
“…SGK1, a serine/threonine that is kinase-dependent on phosphatidylinositol 3-kinase, is expressed in many tissue types and induced by several hormones, such as glucocorticoids and androgens [ 22 ]. SGK1 has been shown to regulate glucose levels [ 23 ], affect various physiological functions, and plays an active role in the pathophysiology of obesity, diabetes, autoimmune diseases, and cancer [ 23 ]. SGK1 expression is upregulated in some tumors, such as breast cancer [ 24 ], multiple myelomas [ 25 ], and lung cancer, and it is downregulated in others, such as prostate cancer [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…SGK1, a serine/threonine that is kinase-dependent on phosphatidylinositol 3-kinase, is expressed in many tissue types and induced by several hormones, such as glucocorticoids and androgens [ 22 ]. SGK1 has been shown to regulate glucose levels [ 23 ], affect various physiological functions, and plays an active role in the pathophysiology of obesity, diabetes, autoimmune diseases, and cancer [ 23 ]. SGK1 expression is upregulated in some tumors, such as breast cancer [ 24 ], multiple myelomas [ 25 ], and lung cancer, and it is downregulated in others, such as prostate cancer [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…SGK 1 phosphorylation of FOXO1 and FOXO3 via PI3K/Akt signaling pathway. SGK1 affect many multiple physiologic processes via phosphorylation of downstream proteins [49][50][51]. SGK1 promotes adipocyte differentiation and controls cell proliferation by regulating the phosphorylation level of FOXO1 and FOXO3, respectively [52,53].…”
Section: Discussionmentioning
confidence: 99%
“…SGK1 affected multiple physiologic processes via phosphorylation of downstream proteins [43][44][45]. SGK1 overexpression improved the hypercholesterolemic induced by diet or genetically obese due to disorder of lipid metabolism in mice [46].…”
Section: Sgk1 Affects the Phosphorylation And Expression Of Foxo1 And...mentioning
confidence: 99%